These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 37452997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2018; 9():2329. PubMed ID: 30487789
    [Abstract] [Full Text] [Related]

  • 6. C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature.
    Fernandez-Ruiz R, Blank RB, Wu M, Belmont HM.
    Lupus; 2021 Sep; 30(10):1671-1678. PubMed ID: 34192954
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.
    Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
    [Abstract] [Full Text] [Related]

  • 9. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F, Bravo García-Morato M, Nozal P, Garrido S, Tortajada A, Rodríguez de Córdoba S, López-Trascasa M.
    Clin Exp Immunol; 2016 Apr 15; 184(1):118-25. PubMed ID: 26660535
    [Abstract] [Full Text] [Related]

  • 16. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov 15; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 17. C3 glomerulopathy.
    Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P.
    Contrib Nephrol; 2013 Nov 15; 181():185-93. PubMed ID: 23689580
    [Abstract] [Full Text] [Related]

  • 18. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM, van de Kar NCAJ, van Kraaij SAW, Sarlea SA, Gracchi V, Engels FAPT, Dorresteijn EM, van der Deure J, Duineveld C, Wetzels JFM, van den Heuvel LPWJ, Volokhina EB.
    Front Immunol; 2021 Nov 15; 12():715704. PubMed ID: 34456924
    [Abstract] [Full Text] [Related]

  • 19. C3 nephritic factor associated with C3 glomerulopathy in children.
    Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Frémeaux-Bacchi V, Pietrement C.
    Pediatr Nephrol; 2014 Jan 15; 29(1):85-94. PubMed ID: 24068526
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.